FEXOFENADINE-DRLA fexofenadine hydrochloride 120 mg film coated tablet blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

fexofenadine hydrochloride, Quantity: 120 mg

Commercializzato da:

Dr Reddys Laboratories Australia Pty Ltd

INN (Nome Internazionale):

Fexofenadine hydrochloride

Forma farmaceutica:

Tablet, film coated

Composizione:

Excipient Ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; mannitol; croscarmellose sodium; powdered cellulose; titanium dioxide; hypromellose; allura red AC aluminium lake; iron oxide black; macrogol 400

Via di somministrazione:

Oral

Confezione:

10's, 20's and 30's, 50, 60, 70, 80, 90,100

Tipo di ricetta:

(S2) Pharmacy Medicine

Indicazioni terapeutiche:

Seasonal allergic rhinitis, in adults and children aged 12 years and over.

Dettagli prodotto:

Visual Identification: Pink coloured, oval shaped, biconvex tablets, debossed with "FXF" one side and "120" on other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2011-05-02